-
- Nov 8/24
World-first stem-cell treatment restores vision in people - Nov 7/24
Nasal spray made from stem cell-derived vesicles could treat Alzheimer’s disease - Nov 7/24
Researchers are one step closer to developing cell-based therapy for hypothyroidism - Nov 7/24
Sarepta scraps a Duchenne drug as gene therapy sales rise - Nov 6/24
How to overcome immune rejection in iPSC-based gene therapy - Nov 6/24
Parallel platform approach slashes process development time - Nov 6/24
How this ‘switchable’ CAR-T therapy sets its sights on deadly brain cancer - Nov 6/24
Ring Therapeutics calls on Singapore research agencies for gene therapy R&D partnership - Nov 6/24
Sickle cell patient dies in gene-therapy trial - Nov 6/24
Gene editing with CRISPR may introduce new defects - Nov 6/24
Stem cells can tailor their role in gene therapy based on the underlying disease, study suggests - Nov 6/24
Allogeneic: The next stage for the cell therapy story - Nov 5/24
On the cusp of a CAR T cell cure for lupus - Nov 5/24
Unlocking AAV gene therapy potential: The role of successful characterization - Nov 4/24
Space-grown stem cells show promise for accelerating biotherapies - Nov 4/24
FDA lifts clinical holds placed on 3 CAR T-cell therapy trials - Nov 4/24
CAR T and related therapies home in on autoimmune disease - Nov 2/24
How a breakthrough gene-editing tool will help the world cope with climate change - Nov 1/24
Stem cell finding casts doubt on popular theory of direct reprogramming - Nov 1/24
‘It was a good lesson’: FDA reconsiders CAR-T boxed warning on secondary cancers, Peter Marks says - Nov 1/24
Facing up to the challenges in cell therapy - Nov 1/24
Outpatient CAR T: Safe, effective, accessible - Oct 31/24
The 2024 biotech graveyard - Oct 31/24
Scripps Research advances breakthrough regenerative medicines to reverse aging-related diseases - Oct 30/24
AABB introduces new Cell and Gene Therapy Standards for Pharmacy - Oct 30/24
Brain cells reprogrammed into neurons breaks new ground in regenerative medicine - Oct 30/24
New device enables real-time monitoring of stem cell growth - Oct 30/24
Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies? - Oct 30/24
Behind the breakthroughs: How to turn $1,000,000 CAR Ts into ‘real’ medicines - Oct 29/24
Nerve fibre growth troubled with disease, may affect gene therapy - Oct 29/24
A new gene therapy technique aims to deliver treatment before birth - Oct 29/24
Modified stem cell therapy aids familial Parkinson’s motor function - Oct 29/24
Exosomes are touted as a trendy cure-all. We don’t know if they work - Oct 28/24
Viva in vivo: The next generation of cell therapy is fast approaching - Oct 28/24
Researchers discover underlying mechanisms that make CRISPR an effective gene editing tool - Oct 26/24
Discovery of stem-like CD4 T cells offers new hope for cancer immunotherapy - Oct 26/24
Preclinical studies test novel gene therapy for treating IgA nephropathy - Oct 25/24
UCLA researchers uncover novel role of protein GPNMB in heart repair - Oct 25/24
Towards a new future within tissue regenerative medicine - Oct 24/24
Experts call for clear and concise regulation of exosome-based treatments - Oct 24/24
Cryopreservation: Freezing time in cell and gene - Oct 24/24
Using microgravity to address limitations of tissue engineering techniques - Oct 24/24
Study identifies key blood stem cells in immune system aging - Oct 24/24
Roche expands Dyno gene therapy collab, bets up to $1B-plus that AI can help design better delivery tools - Oct 23/24
Novel techniques may provide ‘incredible’ benefits to enhance CAR T-cell therapy - Oct 22/24
Modeling diabetes in minipigs for more accurate testing of potential cell therapies - Oct 22/24
Inherited retinal diseases meet their therapeutic match - Oct 22/24
Editas, changing course again, looks to partner lead CRISPR therapy - Oct 22/24
On/off switch for CAR-T cell therapy shows early promise - Oct 21/24
Deciphering the language of cells: How they sense and respond to mechanical forces - Oct 21/24
Gladstone to present 2024 Ogawa-Yamanaka Stem Cell Prize to neuroscientist Rusty Gage - Oct 21/24
Re-engineered, blue light-activated immune cells penetrate and kill solid tumours - Oct 21/24
Perplexing results from Duchenne muscular dystrophy trial raise questions about gene therapies - Oct 21/24
The role of automation in industrializing cell therapy manufacturing
- Nov 8/24